A notable advancement in glucose care is emerging with the approval of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and provides https://kallumpqam868804.wikikali.com/2118995/revolutionary_introduction_tirzepatide_dose_for_glucose_management